Apixaban Reduces the Risk of Hemorrhage in VTE Patients
... This article was written by Jesse Holzman, MD, and internal medicine resident at the University of California and a ... Findings presented at the 2020 American Society of Hematology Annual Meeting & Exposition suggest that ejection ... A regimen of ixazomib, cyclophosphamide, and dexamethasone produced hematologic responses in 57% of patients with ... Individuals with light-chain (AL) amyloidosis have higher odds of severe SARS-CoV-2 infection or mortality compared with ... Therapy with isatuximab for previously treated light-chain (AL) amyloidosis was found to be effective and safe, ... Maintenance therapy following autologous hematopoietic cell transplantation (AHCT) did not significantly impact survival ... Researchers from the Washington University School of Medicine developed a prediction model that may improve timely ... The ratio of left ventricular (LV) mass to electrocardiographic (EKG) voltage was associated with subsequent heart ... In light-chain (AL) amyloidosis, a rare plasma cell disease marked by excess deposit of protein in the organs, the goal ... Light-chain (AL) amyloidosis is a rare immune system disorder marked by the buildup of malformed proteins, called ... Right heart evaluation may be considered a marker for clinical risk stratification in patients with cardiac amyloidosis ... Findings published in Clinical Research in Cardiology showed that non-invasive cardiovascular magnetic resonance (CMR) ... Researchers from the Cedars-Sinai Medical Center found that cardiac transplantation can be safely performed in select ... A study published in the Journal of Nuclear Cardiology found that the 18F-flutemetamol positron emission tomography ... A study published in Blood Cancer Journal found that pleural effusion was strongly associated with poor right ... Racial and ethnic minorities comprise only a small percentage of patients seen at specialized treatment centers for ... A study from researchers at the University of Pavia in Italy, confirmed that current response criteria for an amyloid ... A new study from an Israeli research team observed favorable safety, tolerability, and efficacy of daratumumab for the ...